What You Should Know:
- The FDA has cleared Dexcom G7 continuous glucose monitoring (CGM) system in the U.S. for people with all types of diabetes ages two years and older, giving more people than ever access to a powerfully simple diabetes management solution.
- Cleared as an integrated continuous glucose monitoring (iCGM) system, Dexcom G7 will be part of the most connected CGM ecosystem in the world, with real-time connectivity that can drive integrated insulin delivery systems, connect
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Baptist Health Taps TytoCare to Enhance Virtual Care to Patients
What You Should Know:
- TytoCare has partnered with Baptist Health, a full-spectrum health system, to bring Tytocare’s virtual care solutions to patients in Kentucky and Indiana.
- As part of the partnership, Baptist Health will integrate TytoCare’s Home Smart Clinic solution into its current telehealth offering, enhancing the health system’s ability to diagnose and treat patients with in-depth, remote physical examinations during virtual visits, including urgent
Read More
Grow Therapy Announces Multi-State Expansion, Increasing Access to Quality Mental Healthcare
What You Should Know:
- Grow Therapy, a provider-centric mental health group using technology to make high-quality mental healthcare accessible and affordable to all Americans, today announced the expansion of its services to multiple states across the U.S.
- The expansion includes availability in 22 new states, making Grow Therapy services now available in 36 states. The expansion also means the addition of 601 new therapists being added to the Grow Therapy marketplace (285 in the newly
Read More
Enthea Secures $2M to Expand Psychedelic Healthcare Provider Network
What You Should Know:
- Enthea, the first provider of insurance plans for psychedelic healthcare, has announced a $2M Seed Round raise led by Tabula Rasa Ventures to offer psychedelic-assisted therapy as a workplace benefit.
- The funds will be used to launch Enthea’s services into 40 markets across the U.S. in 2023 as well as grow its customer base and provider network to increase access to new, evidence-based healing options that have proven to be very effective in improving symptoms for
Read More
2022 Telemental Health Regulations Unlock Access and Evolve Compliance Practices
What You Should Know:
- Epstein Becker Green (EBG) recently released its 2022 updates to the Telemental Health Laws survey.
- The 2022 updates report a significant evolution of the telemental health and telehealth industries, including increased regulatory flexibilities that promote increased use of telehealth.
Insights and Trends from Telemental Health’s Survey
The Telemental Health Laws survey is authored by Amy Lerman and Audrey Davis, with support from Jenna Horowitz, Erin
Read More
Research Shows Power of Anumana AI-ECG Algorithms to Detect Heart Conditions
What You Should Know:
- The research is mounting to show that Anumana’s AI-ECG algorithms could dramatically improve screening for cardiovascular disease (CVD), providing early warnings of disease from just a standard electrocardiogram (ECG). Yesterday, a study was published in Nature Medicine that shows an Anumana AI algorithm applied to Apple Watch ECG recordings successfully identified a weak heart pump in patients.
- This follows other recent research findings, published in The
Read More
How Continuous Glucose Monitoring Can Alleviate Language Barriers in Diabetes Care
As an endocrinologist with 19 years of experience in treating patients with diabetes, one of the most important lessons I’ve learned is that communication is key.
Patients with diabetes live with the heavy burden of making choices and taking action every single day to manage their blood glucose levels. Thankfully, advancements in technology have come incredibly far, giving way to tools like continuous glucose monitors (CGM), automated insulin delivery systems and more. But for
Read More
How Virtual-First Clinical Trials Scale Access for Participants
Making clinical trials equitable is one of the biggest challenges we face as an industry. We see this time and again, with one of the latest examples coming in the form of a study published in JAMA Network Open that found substantial underrepresentation of Black patients enrolled in pivotal trials for CAR-T therapy.
Women are another demographic negatively affected by inequality in clinical research. Earlier this month [May 2022] the American Heart Association issued a
Read More
Hims & Hers Appoints Dr. Knoer as First-Ever Chief Pharmacy & Innovation Officer
What You Should Know:
- Hims & Hers Health, Inc. appoints pharmacy industry veteran Dr. Scott Knoer, Pharm.D., MS, FASHP, as the company’s first-ever Chief Pharmacy & Innovation Officer.
- As Chief Pharmacy & Innovation Officer, Dr. Knoer will oversee pharmacy strategy and innovation efforts for Hims & Hers. Knoer will direct efforts to develop proprietary formulations that will make it possible to provide customers with personalized health and wellness advancements. Hims
Read More
Intel Labs & Penn Medicine Uses Privacy-Preserving AI to Identify Brain Tumors
What You Should Know:
- Intel Labs and the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) have completed a joint research study using federated learning – a distributed machine learning (ML) artificial intelligence (AI) approach – to help international healthcare and research institutions identify malignant brain tumors.
- The largest medical federated learning study to date with an unprecedented global dataset examined from 71 institutions across six
Read More
